6 min read
0
The Cost of Conflict: The Interplay of Politics, Profit and Public Health in the mRNA Vaccine Push
The global response to the COVID-19 pandemic has unveiled a complex web of interactions where financial incentives, political influence and public health intersect, often at the expense of integrity and individual health. This article delves into how these conflicts of interest have shaped the narrative and policy surrounding mRNA vaccines, particularly in the United States. Financial Interests Over Public Health The rapid deployment of mRNA vaccines during the COVID-19 crisis was underpinned by significant financial stakes. Both pharmaceutical companies and political figures had substantial investments in the success of these vaccines. For instance, reports have highlighted how entities like the National Institutes of Health (NIH) in the U.S. received millions in royalties from vaccine manufacturers like Moderna, suggesting a potential bias in promoting these vaccines even before full…